ADAntony Devasia

Antony Devasia

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Antony Devasia has a total of 68 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Effect of intravenous mannitol on renal function in patients undergoing laparoscopic nephron-sparing surgery: a randomized, double-blinded trial

    by Abhilash Cheriyan, Ramamani Mariappan, Lakshmanan Jeyaseelan, Prasanna Samuel, S. Annadurai, Arun Jacob Philip George, Antony Devasia, Santosh Kumar, Nirmal Thampi John

    Purpose Mannitol is often used as a renoprotective agent in nephron-sparing surgery (NSS) prior to renal vessel clamping. Although there is some recent evidence questioning its role, these studies used a fixed dose of mannitol and studied a heterogeneous group that included both laparoscopic and open NSS. This trial aimed to investigate whether renal-functional outcomes in patients undergoing laparoscopic NSS are equivalent in patients receiving weight-based mannitol and those administered placebo. Materials and methods In this prospective, randomized, double-blinded, placebo-controlled trial, 100 patients who underwent laparoscopic NSS with an estimated glomerular filtration rate (eGFR) > 45 ml/min/1.73 m2 were randomized to receive either weight-based mannitol (0.25 g/kg) or placebo (0.9% saline) 30 min prior to vessel clamping. Standardized anesthesia and fluid management protocols were followed. A predefined equivalence margin of 8 units of eGFR was used to define equivalence between the groups. The primary outcome was the difference in eGFR between the two groups at 6 months after surgery. The secondary outcomes were the difference in eGFR on days 2 and 10, blood loss, and complications between groups. Results Baseline characteristics were comparable between the groups. The mean difference in eGFR of the two groups at 6 months from baseline was 2.25 (95%CI − 1.9, 6.4), which was within the margin for equivalence. Similarly, the mean difference (95% CI) for eGFR at day 2 and day 10 from the baseline was 0.58 (95% CI − 5.5, 6.6) and -0.38 (95%CI − 4.9, 4.1), respectively, suggesting equivalence between the groups. Complication rates were comparable between the two groups. Conclusions Intraoperative mannitol administration was equivalent to placebo for renal-functional outcomes (eGFR) of patients undergoing laparoscopic NSS suggesting that this practice can be discontinued.


  • Gossypiboma: A Sheep in a Wolf’s Clothing

    by Angela Mary George, Vinotha Thomas, C. Anuradha, Antony Devasia, Dhanya Susan Thomas, Anitha Thomas

  • Satisfaction and genital perception after orchiectomy for prostate cancer: does the technique matter? A randomized trial

    by Onkar Singh, Partho Mukherjee, M. S. Sakthivel, Cornerstone Wann, A. J. P. George, Rajesh Gopalakrishnan, Belavendra Antonisamy, Antony Devasia, Santosh Kumar, Nitin S. Kekre, et al.

    Objectives Bilateral extracapsular or total orchiectomy (BEO) for prostate cancer is presumed to have psychological consequences after the surgery due to perception of an empty scrotum. Bilateral subcapsular orchiectomy (BSO) was designed to preserve perception of palpable testes. We compared the patients' satisfaction and genital perception following BEO and BSO. Materials and methods Prostate cancer patients eligible for androgen deprivation therapy who opted for orchiectomy were enrolled in prospective randomized study. Patients with bleeding disorder or uncorrected coagulopathy, poor performance score, and psychiatric problems were excluded. Outlook to life and own health in-general, overall satisfaction to the procedure and genital perception was evaluated using modified Fugl-Meyer questionnaire (FMQ) which was administered before and after 3 months of the surgery. Patients were randomized to BEO and BSO groups at the time of surgery using block randomization. Primary outcome was to compare the genital perception of testicular loss and patients’ satisfaction to BSO and BEO. Secondary outcomes included testosterone and PSA control, operative time, and complications. Results Total 35 patients were enrolled in each group which was comparable. There was no difference in PSA control at 3 months. Mean operative time and blood loss were significantly lesser in BEO group. FMQ score at 3 months did not show significant difference. Majority of the patients in both groups were satisfied with procedure and the aesthetic value of scrotum after surgery. However, 84% in BSO group did not feel that testes were removed on self-examination, as compared to 28% in BEO group. Majority patients in both groups did not report physical or psychological discomfort from change in scrotal content. Conclusions Results showed that patients’ satisfaction and genital perception following BSO and BEO were similar. Feeling of remaining intrascrotal contents after BSO did not had added psychological advantage in terms of perception of genitalia.


  • Post‐transplant complications, patient, and graft survival in pediatric and adolescent kidney transplant recipients at a tropical tertiary care center across two immunosuppression eras

    by Anjali Mohapatra, Anna T. Valson, Vellaichamy M. Annapandian, Vinoi George David, Suceena Alexander, Shibu Jacob, Shailesh Kakde, Santosh Kumar, Antony Devasia, Theophilus S. Vijayakumar, et al.

    Background: We report pediatric PAKT patient and graft outcomes at a large tropical tertiary center spanning two transplant eras.Methods: In this retrospective cohort study, all children ≤18 years who underwent kidney transplantation at our center between 1991 and 2016 were included. Data pertaining to their baseline characteristics, post‐transplant events, and outcome were retrieved from transplant records and compared between transplant eras (1991‐2005 and 2006‐2016).Results: A total of 139 children (mean age 15.2 ± 2.9 years) underwent PAKT during this period. The incidence of UTIs, CMV disease, BKVN, invasive fungal infections, new‐onset diabetes after transplant, leucopenia, and recurrent NKD was higher in the 2006‐2016 era (P < .001 for all), while 1‐year cumulative BPAR was comparable (P = .100). Five‐year graft and patient survival in the two eras were 89.9% and 94.2% (P = .365) and 92.1% and 95.3% (P = .739), respectively. Incidence of CMV disease, BKVN, graft loss, and death was lower in the calcineurin withdrawal group. Non‐adherence accounted for 36% of graft loss; infections caused 43.7% of deaths. On multivariate Cox proportional hazards analysis, independent predictors for graft loss were UTIs and blood transfusion naïve status and for death were serious infections and glomerular NKD.Conclusions: PAKT in India has excellent long‐term graft outcomes, though patient outcomes remain suboptimal owing to a high burden of infections. Current immunosuppression protocols need to be re‐examined to balance infection risk, graft, and patient survival.


  • Scrotal pop off in a congenital anterior urethral diverticulum

    by N. Abrol, A.V. Deshpande, C.S. Berry, A. Devasia


  • Open Access

    Second transurethral resection in T1G3 bladder tumors - Selectively avoidable?

    by Antony Devasia, Francis S Katumalla, Ramani Kumar, Santosh Kumar, Ninan Chacko, Nitin Kekre

    Aim : To assess the need of a second transurethral resection (TUR) in select T1G3 bladder tumor patients. Materials and Methods : All the pT1G3 bladder tumors diagnosed during the period between January 2005 and December 2008 were included. Second TUR was routinely performed in all the pT1G3 bladder tumors within 4-6 weeks. Fifty out of the 68 patients with T1G3 underwent a second TUR and were retrospectively reviewed. The primary bladder lesions were grouped as solitary papillary, multiple papillary and sessile lesions. Statistical analysis was performed using STATA version 11 (STATA Corp., Texas, USA). Results : Forty percent (n = 20) of the lesions were solitary papillary, 48% (n = 24) were multiple papillary and 12% (n = 6) were sessile lesions. All our resections had muscularis propria sampled at the end of the resection and separately sent for histopathological examination (HPE), which showed them to be tumor free. Thirty-six percent of patients had residual disease at the second resection and 4% were upstaged. Ninety-five percent of the patients (n = 19) with solitary papillary lesions did not have any residual disease and 50% (n = 12) of the multiple papillary and 83.3% (n = 5) of the sessile group had residual disease at the second TUR. Conclusions : Patients with T1G3 tumors do not represent a homogenous group. Second TUR is recommended in patients with high-grade T1 urothelial bladder carcinoma as it identifies residual disease and invasive disease. Solitary papillary lesions may be the only group where the need for the second TUR is questionable.


  • Open Access

    A NORMOGRAM OF EARLY GRAFT FUNCTION TO PREDICT ONE-YEAR OUTCOME OF LIVING RELATED RENAL TRANSPLANTS

    by G. Basu, L. Jeyaseelan, S. Gang, D. Daniel, S. Varughese, M. Sundaram, A. Devasia, N. Kekre, M. Rajapurkar, V. Tamilarasi, et al.

    An abstract is unavailable. This article is available as a PDF only.

  • Thimble bladder

    by Karthikeyan Aswathaman, Antony Devasia